Stay updated with breaking news from Jared Bearss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat...
Halia Therapeutics believes it is on the forefront of research to target chronic inflammation to treat neurodegeneration and inflammatory diseases. Chronic inflammation causes more health issues than the average person may realize. It causes arthritis, anemia, Alzheimer’s, bone marrow disorders and many other diseases. Started in 2017, Halia Therapeutics has now expanded to a new […]
Halia Therapeutics presented data today on its NLRP3 inhibitor program at today's 10th Annual Neurodegenerative Drug Development Summit. Dr. David J.
/PRNewswire/ -- Halia Therapeutics, a biotechnology company that has used a structure-based drug design strategy to discover a series of small molecule...